ERDAFITINIB
|
- $31 - $1400
- Product name: ERDAFITINIB
- CAS: 1346242-81-6
- MF: C25H30N6O2
- MW: 446.54
- EINECS:
- MDL Number:MFCD28502040
- Synonyms:Erdafitinib;Erdafitinib(JNJ-42756493);N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine;N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;Suftalan Zine;N-(3,5-Dimethoxyphenyl)-N'-isopropyl-N-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine;N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine;ERDAFITINIB;JNJ-42756493 ;JNJ 42756493 ;JNJ42756493
31 prices
Selected condition:
Brand
- AK Scientific
- ApexBio Technology
- Axon Medchem
- Biosynth Carbosynth
- Cayman Chemical
- Chemenu
- ChemScene
- Crysdot
- DC Chemicals
- TRC
Package
- 1mg
- 5mg
- 10mg
- 25mg
- 10mM*1mLinDMSO
- 50mg
- 100mg
- 250mg
- 500mg
- 1g
- ManufacturerAK Scientific
- Product number9849BB
- Product descriptionErdafitinib
- Packaging100mg
- Price$414
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB8387
- Product descriptionErdafitinib
- Packaging5mg
- Price$70
- Updated2026-05-06
- Buy
- ManufacturerApexBio Technology
- Product numberB8387
- Product descriptionErdafitinib
- Packaging10mg
- Price$120
- Updated2026-05-06
- Buy
- ManufacturerAxon Medchem
- Product numberAxon4388
- Product descriptionJNJ-42756493
- Packaging50mg
- Price$220
- Updated2026-05-19
- Buy
- ManufacturerAxon Medchem
- Product numberAxon4388
- Product descriptionJNJ-42756493
- Packaging10mg
- Price$88
- Updated2026-05-19
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFE76167
- Product descriptionErdafitinib
- Packaging10mg
- Price$70
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFE76167
- Product descriptionErdafitinib
- Packaging50mg
- Price$170
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFE76167
- Product descriptionErdafitinib
- Packaging500mg
- Price$650
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFE76167
- Product descriptionErdafitinib
- Packaging100mg
- Price$270
- Updated2021-12-16
- Buy
- ManufacturerBiosynth Carbosynth
- Product numberFE76167
- Product descriptionErdafitinib
- Packaging250mg
- Price$400
- Updated2021-12-16
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging25mg
- Price$296
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging25mg
- Price$269
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging10mg
- Price$138
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging5mg
- Price$85
- Updated2024-03-01
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging10mg
- Price$152
- Updated2026-04-30
- Buy
- ManufacturerCayman Chemical
- Product number21813
- Product descriptionJNJ-42756493 ≥98%
- Packaging1mg
- Price$31
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| AK Scientific | 9849BB | Erdafitinib | 100mg | $414 | 2021-12-16 | Buy |
| ApexBio Technology | B8387 | Erdafitinib | 5mg | $70 | 2026-05-06 | Buy |
| ApexBio Technology | B8387 | Erdafitinib | 10mg | $120 | 2026-05-06 | Buy |
| Axon Medchem | Axon4388 | JNJ-42756493 | 50mg | $220 | 2026-05-19 | Buy |
| Axon Medchem | Axon4388 | JNJ-42756493 | 10mg | $88 | 2026-05-19 | Buy |
| Biosynth Carbosynth | FE76167 | Erdafitinib | 10mg | $70 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FE76167 | Erdafitinib | 50mg | $170 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FE76167 | Erdafitinib | 500mg | $650 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FE76167 | Erdafitinib | 100mg | $270 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FE76167 | Erdafitinib | 250mg | $400 | 2021-12-16 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 25mg | $296 | 2026-04-30 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 25mg | $269 | 2024-03-01 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 10mg | $138 | 2024-03-01 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 5mg | $85 | 2024-03-01 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 10mg | $152 | 2026-04-30 | Buy |
| Cayman Chemical | 21813 | JNJ-42756493 ≥98% | 1mg | $31 | 2024-03-01 | Buy |
Properties
Melting point :136-140°C
Boiling point :662.3±55.0 °C(Predicted)
Density :1.20±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
pka :9.45±0.29(Predicted)
form :Solid
color :Yellow
InChI :InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
InChIKey :OLAHOMJCDNXHFI-UHFFFAOYSA-N
SMILES :C(N(C1=CC(OC)=CC(OC)=C1)C1=CC=C2C(=C1)N=C(C1=CN(C)N=C1)C=N2)CNC(C)C
Boiling point :662.3±55.0 °C(Predicted)
Density :1.20±0.1 g/cm3(Predicted)
storage temp. :-20°C Freezer, Under inert atmosphere
solubility :DMSO (Slightly), Methanol (Slightly)
pka :9.45±0.29(Predicted)
form :Solid
color :Yellow
InChI :InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3
InChIKey :OLAHOMJCDNXHFI-UHFFFAOYSA-N
SMILES :C(N(C1=CC(OC)=CC(OC)=C1)C1=CC=C2C(=C1)N=C(C1=CN(C)N=C1)C=N2)CNC(C)C
Safety Information
| Symbol(GHS): |
![]() ![]()
|
|||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Danger | |||||||||||||||||||||||||||||||||||||||||||||||||
| Hazard statements: |
|
|||||||||||||||||||||||||||||||||||||||||||||||||
| Precautionary statements: |
|
Description
Erdafitinib is an oral pan-FGFR (1-4) inhibitor with has demonstrated promising activity in patients with metastatic or unresectable UC and other histologies (eg, cholangiocarcinoma) with FGFR alterations. It is used in the therapy of locally advanced, unresectable or metastatic urothelial carcinoma. Erdafitinib has been associated with a high rate of serum enzyme elevations during therapy, but has not been linked to cases of clinically apparent acute liver injury.Suppliers and manufacturers
ATK CHEMICAL COMPANY LIMITED
BOC Sciences
Hubei Ipure Biology Co., Ltd
HANGZHOU CLAP TECHNOLOGY CO.,LTD
Changzhou Xuanming Pharmaceutical Technology Co., Ltd.
Finetech Industry Limited






